NCT00960739 Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma Status COMPLETED Phase PHASE2
NCT00958971 Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00958841 Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin Status TERMINATED Phase PHASE2
NCT00958022 Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00956293 Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program Status TERMINATED Phase PHASE4
NCT00952991 The Effects of LAF237 on Gastric Function in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00946647 A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). Status COMPLETED Phase PHASE1/PHASE2
NCT00941798 Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma Status COMPLETED Phase PHASE2
NCT00941031 AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE2
NCT00940602 Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Status COMPLETED Phase PHASE2
NCT00940563 A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors Status COMPLETED Phase PHASE2
NCT00940160 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00939588 Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients Status COMPLETED Phase PHASE2
NCT00939159 Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Status TERMINATED Phase PHASE2
NCT00938860 Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C Status COMPLETED Phase PHASE4
NCT00935961 RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00934544 Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial Status COMPLETED Phase PHASE3
NCT00933920 Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE1
NCT00931762 A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis Status TERMINATED Phase PHASE2
NCT00930475 Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer Status UNKNOWN Phase PHASE1/PHASE2